Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Enhertu
Pharma
AZ's Enhertu, Akeso's bispecifics win reimbursement in China
While AZ/Daiichi's Enhertu and Roche's Polivy earned national reimbursement in China, Gilead's Trodelvy and Pfizer's Besponsa didn't.
Angus Liu
Dec 4, 2024 12:52pm
Jazz's HER2 bispecific snags FDA nod to rival Enhertu
Nov 21, 2024 7:53am
NICE says AZ, Daiichi failed to propose fair price on Enhertu
Nov 19, 2024 11:08am
Merck and BioNTech's I-O bispecific buys—Fierce Pharma Asia
Nov 15, 2024 8:20am
Daiichi enlists Alteogen for subcutaneous Enhertu in $300M deal
Nov 8, 2024 11:19am
Daiichi, Fosun, Yuhan and more—Fierce Pharma Asia
Sep 27, 2024 10:15am
